Assessing the effect of weight and weight loss in obese persons with type 2 diabetes.

Authors:
Curtis B; Hayes RP; Fehnel S; Zografos L.

Journal:
Diabetes Metab Syndr Obes

Publication Year: 2008

PMCID:
PMC3052714

PMID:
21437152

View on PubMed View on PMC
Journal Information

Full Title: Diabetes Metab Syndr Obes

Abbreviation: Diabetes Metab Syndr Obes

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology & Metabolism

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Associations of Serum Uric Acid to High-Density Lipoprotein Cholesterol Ratio with Trunk Fat Mass a…
Wang Y; Xu Y; Hu T and 5 more (2024) - Transparency Score: 3/6
A Systematic Review of the Economic Burden of Diabetes in Eastern Mediterranean Region Countries.
Arshad MS; Alqahtani F; Rasool MF. (2024) - Transparency Score: 4/6
Claudin-2 Mediates the Proximal Tubular Epithelial Cell-Fibroblast Crosstalk via Paracrine CTGF.
Guo C; Jiao M; Cui Y and 4 more (2024) - Transparency Score: 3/6
Clinical Evidence of the Relationship Between Alanine Aminotransferase and Diabetic Kidney Disease.
Bi Y; Yang Y; Yuan X and 4 more (2024) - Transparency Score: 3/6
Construction of a Nomogram-Based Prediction Model for the Risk of Diabetic Kidney Disease in T2DM.
Wang X; Liu X; Zhao J and 2 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosures: BC and RPH are employees of Eli Lilly and Co. SF and LZ are employees of RTI Health Solutions."

Evidence found in paper:

"Financial support for this research was provided Eli Lilly and Co."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025